NeoMedLight,
Innovating through light, treating with precision

At the crossroads of medical innovation and photonic technology, NeoMedLight is transforming the management of oncology side effects and the treatment of newborn jaundice.

CareMin650

Next-generation PBM for supportive care in oncology.

Discover CareMin650

BiliCocoon

BiliCocoon® rethinking neonatal phototherapy.

Discover BiliCocoon

NeoMedLight is ISO 13485 certified. The CareMin650 and BiliCocoon devices are CE-marked and manufactured in France.
BiliCocoon® is FDA-cleared (510(k) Clearance).

 

BiliCocoon Device (User Centers)     BiliCocoon Device (Distributors)

CareMin Device (User Centers)    CareMin Device (Distributors)

We operate across two clinical areas

In oncology

In oncology, our CareMin650™ device uses photobiomodulation to prevent and treat radiation- and chemotherapy-induced mucositis and dermatitis. These are severe, painful complications that affect cancer patients’ quality of life and can sometimes compromise treatment continuity. A significant clinical need that has long remained without an effective response.

In neonatology

In neonatology, our BiliCocoon® device uses phototherapy to treat neonatal jaundice, a common hyperbilirubinaemia that affects the majority of newborns.

Now compatible with home use thanks to the bag system, the treatment integrates naturally into infant care without separating the child from their parents. This approach is centred on the family bond, long relegated to a secondary concern amid hospital constraints, and points to significant economic benefits for healthcare facilities.

Discover Neomedlight

 


  • Made in France

  • Patented devices

  • ISO 13485 certified

Contact NeoMedLight

NeoMedLight develops innovative medical devices for improved phototherapy delivery. The company relies on innovative, unique and exclusive technology enabling light emission through woven optical fibres.

Contact us